Spondylitis, Ankylosing Clinical Trial
Official title:
Tai Chi in Patients With Ankylosing Spondylitis
Ankylosing Spondylitis (AS) is a chronic inflammatory rheumatic disease that causes a
decrease in physical activity, fatigue, sleep problems and psychological consequences such as
depression, anxiety and stress by primarily affecting the sacroiliac joint and spine. The aim
of the treatment of AS is to prevent the hardness and flexion deformity associated with the
disease; to maintain the patient's healthy psychological and physical condition. The first
step in the treatment of AS; Pharmacological treatment of NSAIDs or Anti-TNFs along with
exercise. Exercise, especially pain and immobility symptoms control provides patients with
disease is an advantage.
Tai Chi Chuan or Taiji is a traditional Chinese exercise method that has been applied for
more than 300 years. Exercises based on Chinese medicine and martial arts. It is a
combination of physical exercise and relaxation techniques and is used to improve the mental
and physical health of individuals. In literature, balance, strength, coordination, postural
control, agility, reaction time, flexibility has attracted attention for developing such
factors. In addition, it increases muscle strength in elderly people and decreases the risk
of falling; Rheumatoid arthritis and Osteoarthritis-related symptoms have been reported to
improve in a positive way. In the literature, there is only one study examining the efficacy
of Tai Chi in AS patients. According to the results of this study, Tai Chi has a positive
effect on disease activity and flexibility of patients with AS.
Although there is consensus on exercise role in the treatment of AS, when the literature is
reviewed, it is seen that the strict and definite guidelines on the type and frequency of
exercises are not yet described. There is no defined protocol for which specific exercise is
appropriate in AS. The literature considers that more information is needed on the various
physical therapy programs related to intensity, frequency and duration to determine the most
appropriate activity for the disease.
The aim of this study was to investigate the effect of Tai Chi exercises on functionality,
disease activity, functional exercise capacity, spinal mobility, lower extremity strength and
quality of life in AS patients with biological agents.
At least 36 AS patients followed-up by Antalya Training and Research Hospital, who are
receiving Anti-TNF therapy and who do not have any other disease affecting their functions
will be included in the study. There were 18 patients in the conventional treatment group and
18 patients in the Tai Chi group.
After the demographic data of AS patients were recorded, Bath AS Disease Activity Index
(BASDAI), Bath AS Disease Activity Index (BASFI) and Bath AS Metrology Index (BASMI),
respectively, to be used for activity and basic measurements of the disease, 6 minutes
walking test to measure aerobic capacity , Cognitive Exercise Therapy Approach Scale and
Ankylosing Spondylitis Quality of Life Questionnaire to be used for quality of life, 30
second sit-down test to evaluate the lower extremity strength. In addition, 10-20 ml (1-2
tubes) of blood will be taken from the patient's arm, the amount of substances such as
erythrocyte sedimentation rate (ESR) and C reactive protein (CRP) in the blood will be
measured. Patients will not be charged any fee related to this process. Evaluation methods
will be applied to the cases before the start of training and after the completion of the
training.
For the training, both patient groups were randomly divided into two groups: the first group
was treated with conventional treatment and the second group with Tai Chi training. The
training will last 10 weeks.
Conventional treatment; stretching for the cervical, thoracic and lumbar flexibility,
shoulder circumference, hamstring and erector spinal muscles, strengthening exercises for
abdominal, back and proximal muscles. The exercises that will be taught in detail to each
stage of the patient will be performed at home by the patient for 60 minutes, 2 days a week.
The patients will be inspected and controlled by monthly controls.
Tai Chi exercise method, which is composed of combination of physical exercise and relaxation
techniques, will be applied by an experienced physiotherapist who is trained with Tai Chi.
The training will take 60 minutes, 2 days a week and 10 weeks in total.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01208207 -
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
|
Phase 3 | |
Completed |
NCT02509026 -
Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
|
Phase 4 | |
Completed |
NCT02704845 -
Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain
|
N/A | |
Terminated |
NCT01209702 -
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs
|
Phase 3 | |
Terminated |
NCT01209689 -
A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy
|
Phase 3 | |
Terminated |
NCT00766402 -
An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)
|
Phase 4 | |
Completed |
NCT00000433 -
Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
|
Phase 2 | |
Completed |
NCT00779012 -
A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)
|
Phase 4 | |
Completed |
NCT00779935 -
Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)
|
Phase 4 | |
Completed |
NCT01863732 -
Extension in AS: Sustainability of Benefits, Safety and Tolerability
|
Phase 3 | |
Recruiting |
NCT05879419 -
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
|
Phase 4 | |
Completed |
NCT01567878 -
Ultrasound of Enthesis in Patients With Ankylosing Spondylitis: a Comparative Study With Health Subjects
|
N/A | |
Completed |
NCT01188655 -
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
|
N/A | |
Completed |
NCT00760669 -
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
|
Phase 4 | |
Completed |
NCT02159053 -
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
|
Phase 3 | |
Completed |
NCT00202865 -
Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)
|
Phase 3 | |
Completed |
NCT02374502 -
Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial
|
N/A | |
Withdrawn |
NCT00298012 -
Methotrexate in the Treatment of Axial Spondyloarthritis
|
Phase 4 | |
Terminated |
NCT00273858 -
Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis
|
N/A | |
Completed |
NCT04810715 -
Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction in Patients With Ankylosing Spondylitis
|